跳至主要内容
临床试验/NCT01132547
NCT01132547终止3 期

Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk

University of South Florida14 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
22
试验地点
14
主要终点
Participant With Weight Loss ≥ 5% at the 8- Week Assessment When Compared to Baseline

研究概览

简要总结

RATIONALE: Cyproheptadine hydrochloride may prevent weight loss caused by cancer or cancer treatment. It is not yet known whether cyproheptadine is more effective than a placebo in preventing weight loss in young patients receiving chemotherapy for cancer.

PURPOSE: This randomized phase III trial is studying cyproheptadine hydrochloride to see how well it works in preventing weight loss in young patients receiving chemotherapy for cancer.

详细描述

OBJECTIVES:

Primary

  • To determine the effect of cyproheptadine hydrochloride in the prevention of cancer- or treatment-related weight loss (defined as ≥ 5% reduction in weight from baseline measurement) in children who are initiating a course of moderately or highly emetic chemotherapy.

Secondary

  • To investigate the effect of cyproheptadine HCl on the change in weight for age scores after 8 weeks of study drug administration in comparison to placebo.
  • Investigate the relationship between the secondary outcome variables (prealbumin, triceps skin fold, mid-upper arm circumference, and weight loss)from baseline to end of treatment in each group (treatment and placebo) separately.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
2 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Arm I cyproheptadine hydrochloride

Experimental

Patients receive oral cyproheptadine hydrochloride twice daily for 8 weeks.

干预措施: cyproheptadine hydrochloride (Drug)

Arm II placebo

Placebo Comparator

Patients receive an oral placebo twice daily for 8 weeks.

干预措施: placebo (Other)

结局指标

主要结局

Participant With Weight Loss ≥ 5% at the 8- Week Assessment When Compared to Baseline

时间窗: 8 weeks

Severity of Weight Loss

时间窗: Baseline and 8 weeks

Change from Baseline in Weight Z score

次要结局

  • Pattern of Weight in the Study Population(Baseline and 8 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验